Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength

Interest Coverage 47.52
NAS:THOR's Interest Coverage is ranked lower than
54% of the 222 Companies
in the Global Medical Devices industry.

( Industry Median: 86.37 vs. NAS:THOR: 47.52 )
Ranked among companies with meaningful Interest Coverage only.
NAS:THOR' s Interest Coverage Range Over the Past 10 Years
Min: 0  Med: 0 Max: 47.52
Current: 47.52
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth

More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:THOR's 30-Y Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

THOR Guru Trades in

Q2 2015

THOR Guru Trades in Q2 2015

Jim Simons 202,839 sh (New)
Manning & Napier Advisors, Inc 1,066,760 sh (-12.56%)
» More
Q3 2015

THOR Guru Trades in Q3 2015

Mario Gabelli 298,800 sh (New)
Manning & Napier Advisors, Inc Sold Out
Jim Simons 144,639 sh (-28.69%)
» More
Q4 2015

THOR Guru Trades in Q4 2015

Mario Gabelli Sold Out
Jim Simons Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with THOR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices  
Traded in other countries:TL1.Germany,
Headquarter Location:USA

Thoratec Corporation incorporated in the State of California in 1976 provides mechanical circulatory support with a product portfolio to treat the full range of clinical needs for advanced heart failure patients. It develops, manufactures and markets proprietary medical devices used for circulatory support. Following the sale of ITC in 2010, the Company has one operating segment: Cardiovascular group. This segment is organized and operates to develop and manufacture mechanical circulatory products to support the cardiovascular systems of humans. The Company's VAD products primarily serve patients suffering from late-stage HF. HF is a chronic disease that occurs when degeneration of the heart muscle reduces the pumping power of the heart, causing the heart to become too weak to pump blood at a level sufficient to meet the body's demands. Hospitals that perform open heart surgery and heart transplants are the potential customers for its Thoratec and HeartMate products. The Company estimates that it sells into 293 of these centers. According to the Company's estimates, it is in approximately 149 centers in the United States and 144 centers internationally. Competition from medical device companies and medical device divisions of healthcare companies, pharmaceutical companies and gene- and cell-based therapies is intense and is expected to increase. It therefore continues to expect new competitors both from the pharmacological and the medical device space. Among the medical device competitors are Aachen Innovative Solutions GmbH, AbioMed, Inc., Berlin Heart GmbH, HeartWare International Inc., Jarvik Heart, Inc., Maquet Cardiovascular, LLC (a division of Getinge AB), MicroMed Technology, Inc., Sun Medical Technology Research Corporation, SynCardia Systems, Inc., and Terumo Heart, Inc. All of the Company's proposed products will require regulatory approval prior to commercialization. In particular, medical devices are subject to rigorous pre-clinical testing as a condition of approval by the FDA and by similar authorities in foreign countries.

Guru Investment Theses on Thoratec Corp

Mario Gabelli Comments on Thoratec Corp - Oct 19, 2015

Thoratec Corp. (NASDAQ:THOR)(2.1%) (THOR – $63.26 – NASDAQ), headquartered in Pleasanton, California, designs, manufactures and sells products to treat the full range of clinical needs for patients suffering from advanced heart failure. On July 22, 2015, St. Jude Medical announced that it would acquire the company for $63.50 cash per share in a merger worth $3.4 billion. Following regulatory and shareholder approvals, the transaction is expected to close in the fourth quarter of 2015.

From Mario Gabelli (Trades, Portfolio)'s third quarter 2015 ABC Fund commentary.

Check out Mario Gabelli latest stock trades



Buy Back


Valuation & Return


More Statistics

Revenue (TTM) (Mil) $483.8
EPS (TTM) $ 0.70
Short Percentage of Float4.82%
52-Week Range $25.04 - 63.51
Shares Outstanding (Mil)54.80

Analyst Estimate

Dec15 Dec16
Revenue (Mil $) 489 530
EPS ($) 1.13 1.60
EPS without NRI ($) 1.13 1.60
EPS Growth Rate
(Future 3Y To 5Y Estimate)
Dividends per Share ($)
» More Articles for THOR


Articles On GuruFocus.com
The Gabelli ABC Fund Merger and Arbitrage Shareholder Commentary for Q4 Jan 29 2016 
Mario Gabelli Comments on Thoratec Corp Oct 19 2015 
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Thoratec Corp. of Commencement of Aug 18 2015 
5-year lows: Thoratec Corp, Brady Corp, General Cable Corp, and UTi Worldwide Inc. Aug 25 2014 
5-year lows: Mack-Cali Realty Corp, Thoratec Corp, Brady Corp, and EXCO Resources Inc. Aug 10 2014 
5 Strong Healthcare Stocks For 2012 Mar 24 2012 
Consider These 5 Healthcare Stocks Now Mar 21 2012 
Weekly Guru Bargains Highlights: CSTR, VRX, SAY, THOR, BVN Feb 12 2011 
Weekly Guru Bargains Highlights: SVU, MSI, THOR, JNY, AMLN Jan 23 2011 
Weekly Guru Bargains Highlights: DF, CLWR, THOR, VRX, ASIA Dec 26 2010 

More From Other Websites
Thor Industries Stock Drops Double Digits on Mixed Earnings Mar 07 2017
Top Funds' New Buys: GrubHub Delivers Food, Profit Feb 03 2017
Thoratec Acquisition: The Impact on St. Jude’s Growth Potential Apr 21 2016
How Big Is the St. Jude Medical Threat to Abiomed, Inc. Stock? Apr 19 2016
3 Charts Show Why Abiomed Could Get Bought Apr 09 2016
Read This Before You Sell Abiomed, Inc. Stock Mar 30 2016
Who Were the Outliers in the Consumer Space? Mar 14 2016
Hedge Funds Have This To Say About Thoratec Corporation (THOR) Nov 20 2015
St. Jude Medical, Inc. -- Moody's downgrades St. Jude Medical's ratings to Baa2 from Baa1; outlook... Oct 09 2015
St. Jude Completes Acquisition of Thoratec for $3.3 Billion Oct 09 2015
Thoratec's HeartMate III CE Mark Trial Results Positive Sep 28 2015
Tiny Heart Pumps From Abiomed Save Lives, Lift Stock Sep 16 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)